Sponsored Links 
Warner Chilcott Meets in Q1
Warner Chilcott Ltd.'s (WCRX - Snapshot Report) announced first-quarter EPS, excluding items, of 39 cents, which matched the consensus.
Revenues expanded 7% to $246 million, primarily due to the growth of Doryx, Loestrin 24 FE and Estrace Cream.
Warner Chillcott indicated that it continues to expect fiscal 2009 revenues to range between $1.015 billion and $1.025 billion.
The developer of woman healthcare products also affirmed full-year earnings guidance of $1.55 to $1.60 per share, excluding items, which is in-line with the $1.59 consensus derived from 12 analysts.
WCRX, Zacks #3 Rank ("Hold") stock, is about breakeven today with volume of approximately 616,000, which is lower than the average daily volume of about 1.02 million.
 |
 |
 Share |
 RSS |
 Rate Pos |
 Rate Neg |
 Comment |
|
|
||||||
Loading Stories...Related Content
Loading Stories...Most Popular on Zacks.com
-0.73 %
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
More Zacks Links
| Market Summary | Nov 21, 2009 17:53 pm ET |
Sponsored Links
[CLICK TO CLOSE X]